A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
Mandeep R MehraNir UrielYoshifumi NakaJoseph C ClevelandMelana YuzefpolskayaChristopher T SalernoMary N WalshCarmelo A MilanoChetan B PatelSteven W HutchinsJohn RansomGregory A EwaldAkinobu ItohNirav Y RavalScott C SilvestryRebecca CogswellRanjit JohnArvind BhimarajBrian A BrucknerBrian D LowesJohn Y UmValluvan JeevanandamGabriel SayerAbeel A MangiEzequiel J MolinaFarooq SheikhKeith AaronsonFrancis D PaganiWilliam G CottsAntone J TatoolesAshok BabuDon ChomskyJason N KatzPaul B TessmannDavid DeanArun KrishnamoorthyJoyce ChuangIa TopuriaPoornima SoodDaniel J Goldsteinnull nullPublished in: The New England journal of medicine (2019)
Among patients with advanced heart failure, a fully magnetically levitated centrifugal-flow left ventricular assist device was associated with less frequent need for pump replacement than an axial-flow device and was superior with respect to survival free of disabling stroke or reoperation to replace or remove a malfunctioning device. (Funded by Abbott; MOMENTUM 3 ClinicalTrials.gov number, NCT02224755.).